AG: Pharmaceutical Company Settles Allegations Regarding Marketing Improprieties for Celexa, Lexapro and Levothroid

Attorney General J.B. Van Hollen announced that Forest Laboratories, Inc. and its subsidiary, Forest Pharmaceuticals, Inc., have paid $1,427,527.98 to Wisconsin Medicaid as part of a settlement to resolve allegations of the off-label marketing of Celexa and Lexapro, and filing false claims for Levathroid.

Read the full release.